Skip to content
Screener

Prime Medicine PRME Business Segments — Other segment items

Similar metrics at other companies

Broadridge Financial Solutions logo
BRTotal Reportable Segments — Other segment items
$121.4M+7.5%
Iron Mountain logo
IRMTOTAL REPORTABLE SEGMENTS — Other segment items
$938.34M+13.0%
GLW
GLWTotal Reportable Segments — Other segment items
$2.77B+16.4%
CNN
CNNETotal Reportable Segments — Other segment items
$52.3M+403%
RCI Hospitality Holdings logo
RICKReportable Segments Excluding Other — Other segment items
$0-100%
Veradermics logo
MANEReportable Segment — Other segment items
-$2.63M-411%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$43.3M+18.9%
Net income-$42.1M+19.9%
EPS (diluted)-$0.24+41.5%

Balance sheet

See full
Cash & equivalents$61.1M-9.4%
Total debt$112.5M-6.1%
Total equity$39.8M-34.6%
Total assets$249.0M-10.7%

Cash flow

See full
Operating cash flow-$41.0M+0.9%
CapEx$46.0K-97.1%
Free cash flow-$41.1M+4.4%

Valuation

See full
Market cap$558.64M-10.7%
Enterprise value$609.98M-10.0%

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-373.3%-1,281pp
Debt / equity2.8×+0.9×
Current ratio3.1×-0.5×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:03 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053883
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Facility related10,57713,76520,84324,734
Research costs6,1588,11613,41819,152
General and administrative expenses:
Personnel expenses5,5597,08211,09114,238
Other segment items (1)11,34511,08128,74420,966
Total operating expenses44,43954,49295,949108,338
Total other income, net1,1767862,7081,288
Net loss$(42,109)$(52,591)$(91,231)$(104,481)

Item 1. Financial Statements (unaudited)

FAQ

What is Prime Medicine's business segments — other segment items?
Prime Medicine (PRME) reported business segments — other segment items of $11.35M in Q2 2026.
How has Prime Medicine's business segments — other segment items changed year-over-year?
Prime Medicine's business segments — other segment items increased by 2.4% year-over-year, from $11.08M to $11.35M.
What is the long-term trend for Prime Medicine's business segments — other segment items?
Over 2 years (2023 to 2025), Prime Medicine's business segments — other segment items has grown at a 4.2% compound annual growth rate (CAGR), from $52.79M to $57.34M.
What does business segments — other segment items mean?
Encompasses miscellaneous operating expenses or income items that are specific to a business segment but do not fall into primary categories like personnel or research. These items may include professional fees, travel, or other administrative costs necessary for segment operations. Tracking these helps in understanding the total cost structure and operational overhead of the segment.

Ask your AI about Prime Medicine's business segments — other segment items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude